|
Post by marykudro on Jun 17, 2022 4:43:10 GMT -5
Fulvestrant is an estrogen receptor antagonist that binds to the estrogen receptor competitively with an affinity comparable to that of estradiol and downregulates the ER protein in human breast cancer cells. It is supplied as a white powder. Fulvestrant is supplied in single-dose vials in 250mg/5ml to administer intramuscularly. The active ingredient in the vials is Fulvestrant with inactive ingredients alcohol, benzyl alcohol, and benzyl benzoate, as co-solvents, and made up with Castor Oil. This drug is used in treating patients with HR +Ve metastatic breast cancer in the postmenopausal women with disease progression and HR +Ve, HER2 -Ve advanced breast cancer and palbociclib in women with disease progression after the therapy of endocrine. The recommended dose of Fulvestrant is 500 mg to be administered intramuscularly into the buttocks slowly (1 - 2 minutes per injection) as two 5 mL injections, one in each buttock, on days 1, 15, 29, and once monthly thereafter. Fulvestrant 250 mg is readily available from many generic medicine suppliers. To know more about this drug, contact us on toll-free no. 18008891064.
|
|